(E/Z)-Eltrombopag-13C4

Aladdin

Catalog No.: C09-1130-848
Manufacturer No.: E649644-1mg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Price: $524.71

List Price: $583.01

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

(E/Z)-Eltrombopag- 13 C 4 is a mixture complex of E-Eltrombopag and Z-Eltrombopag, with 13 C labeled. Z-Eltrombopag is an orally active thrombopoietin receptor nonpeptide agonist. Eltrombopag owns thrombopoietic activity, and has been used to research low blood platelet counts with chronic immune thrombocytopenia. Eltrombopag can be used for the research of cardiovascular. Eltrombopag also has highly inhibitory effects against multidrug resistant Staphylococcus aureus. Eltrombopag can induce apoptosis in hepatocellular carcinomab (HCC) as wellForm:SolidIC50& Target:Thrombopoietin Receptor, Staphylococcus aureus , Apoptosis. Specifications and Purity: ≥97.0%. Molecular Formula: C21[13C]4H22N4O4. Molecular Weight: 446.44. PubChem CID: 136205847.

UPC:: 12352005
Condition:: New
Availability:: 8-12 weeks
Weight:: 1.06 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: E649644-1mg
CAS:: 1217230-31-3
Product Size:: 1mg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."